Finance

Beta
Lists
RGEN:NASDAQ
Repligen Corp
123,95 $
+0,99%
(+1,22) 1D
123,95 $
0,00% (0,00)
After hours
Closed: 29 մյս, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for RGEN...
Open
122,82 $
High
125,60 $
Low
121,81 $
Mkt. cap
6,99 մլրդ
Avg. vol.
1,30 մլն
Volume
925,60 հզր
P/E ratio
136,02
52-wk high
175,57 $
52-wk low
100,99 $
EPS
0,91 $
Beta
1,09
Shares outstanding
56,41 մլն
No. of employees
2 հզր
Open
122,82 $
High
125,60 $
Low
121,81 $
Mkt. cap
6,99 մլրդ
Avg. vol.
1,30 մլն
Volume
925,60 հզր
P/E ratio
136,02
52-wk high
175,57 $
52-wk low
100,99 $
EPS
0,91 $
Beta
1,09
Shares outstanding
56,41 մլն
No. of employees
2 հզր
News stories
From sources across the web
Profile
Repligen Corporation is an American life sciences company that develops and manufactures products used in biological drug manufacturing. The company is headquartered in Waltham, Massachusetts, and is listed on the Nasdaq under the symbol RGEN. Wikipedia
About Repligen Corp
CEOTony J. Hunt
Employees2 հզր
Founded1981
HeadquartersՈւոլթեմ, Մասսաչուսեթս, Միացյալ Նահանգներ
Sector-
Websiterepligen.com
Last report
05 մյս, 2026 թ.
Fiscal period
Q1 2026
EPS / Est. (USD)
0,48 $ / 0,39 $
+22,87%beat
Revenue / Est. (USD)
194,26 մլն / 192,35 մլն
+0,99%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
2025 թ. հնս
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
Revenue
182,37 մլն
188,80 մլն
197,91 մլն
194,26 մլն
Cost of goods sold
89,37 մլն
88,29 մլն
94,08 մլն
85,97 մլն
Cost of revenue
89,37 մլն
88,29 մլն
94,08 մլն
85,97 մլն
Research and development expenses
13,97 մլն
14,18 մլն
13,12 մլն
14,46 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
69,41 մլն
73,66 մլն
74,36 մլն
76,54 մլն
Operating expense
83,38 մլն
87,84 մլն
87,48 մլն
90,99 մլն
Total operating expenses
172,75 մլն
176,13 մլն
181,56 մլն
176,96 մլն
Operating income
9,62 մլն
12,68 մլն
16,35 մլն
17,29 մլն
Other non operating income
3,50 մլն
-446,00 հզր
-11,48 մլն
-750,00 հզր
EBT including unusual items
18,22 մլն
17,11 մլն
19,11 մլն
1,77 մլն
EBT excluding unusual items
13,94 մլն
12,96 մլն
17,59 մլն
16,88 մլն
Income tax expense
3,35 մլն
2,20 մլն
5,83 մլն
-6,56 մլն
Effective tax rate
18,39%
12,86%
30,48%
-370,26%
Other operating expenses
-
-
-
-
Net income
14,87 մլն
14,91 մլն
13,29 մլն
8,33 մլն
Net profit margin
8,15%
7,90%
6,71%
4,29%
Earnings per share
0,37
0,46
0,49
0,48
Interest and investment income
6,58 մլն
6,92 մլն
6,75 մլն
6,34 մլն
Interest expense
-5,77 մլն
-5,83 մլն
-5,91 մլն
-6,00 մլն
Net interest expenses
817,00 հզր
1,09 մլն
842,00 հզր
345,00 հզր
Depreciation and amortization charges
-
-
-
-
EBITDA
29,70 մլն
32,69 մլն
36,30 մլն
37,05 մլն
Gain or loss from assets sale
2,16 մլն
-3,38 մլն
-
13,76 մլն
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer